<<Disclaimer: Verify this information before applying it to your situation.>>

Serological Testing for Coeliac Disease in Patients With  Symptoms of
Irritable Bowel Syndrome: A Cost-Effectiveness Analysis

Posted 06/02/2004
It has been suggested that patients with 's'-IBS should be tested for coeliac
 disease.[6,10,11] Our aims were to estimate the potential clinical  and
economic consequences of coeliac disease testing in patients with 's'-IBS.  We
constructed a decision analytic model to explore the number of cases of  coeliac
disease that might be uncovered by competing serological testing  strategies
or up-front small bowel biopsy in a population of patients with  's'-IBS, the
associated gains in quality-adjusted life-years (QALYs), and the  costs per
case detected and QALYs gained.
_http://www.medscape.com/viewarticle/478542?src=mp_
(http://www.medscape.com/viewarticle/478542?src=mp)
Rosalie (NJ)

*Support summarization of posts, reply to the SENDER not the CELIAC List*